January 27, 2011 -- Business Monitor International has increased its short-term forecast for the China pharma market, which includes both pharmaceuticals and TCM products, while it lowered its expectations for the longer term. The business intelligence firm upped its compound annual growth rate for 2009-14 to 16.4%, a jump from 13.8%. But the company lowered its forecast for the size of the 2019 pharmaceutical market in China from $175 billion to $162 billion. More details....